Molbio Diagnostics Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
1,225
- Stock Symbol
-
MOLBIO
- Investments
-
3
- Share Price
-
$15.88
- (As of Friday Closing)
Molbio Diagnostics General Information
Description
Molbio Diagnostics Ltd is a diagnostics company engaged in the business of manufacturing chip-based diagnostic devices, chips and reagents, X-ray equipment, single / dualdetector solutions, developing diagnostic devices, performing tests in the bio-sensing domain, digital pathology, etc. The company's offerings include molecular testing for 30 diseases, including tuberculosis (TB), COVID, Hepatitis B and C, Human immunodeficiency virus (HIV), and Human Papillomavirus (HPV), with 43 assays. The company serves various public health programs, diagnostic laboratories, and private and public hospitals. The majority of revenue is derived from the sale of diagnostic test kits for TB to the Indian central and state government and international aid agencies for their public healthcare programs.
Contact Information
Website
www.molbiodiagnostics.comCorporate Office
- Plot Number L-46, Phase II D
- Verna Industrial Estate
- Verna, Goa 403722
- India
Corporate Office
- Plot Number L-46, Phase II D
- Verna Industrial Estate
- Verna, Goa 403722
- India
Molbio Diagnostics Stock Performance
As of 13-Nov-2026, Molbio Diagnostics’s stock price is $15.88. Its current market cap is $1.83B with 115M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.88 | $14.88 | $9.71 - $17.71 | $1.83B | 115M | 2.75M | $0.15 |
Molbio Diagnostics Financials Summary
As of 30-Sep-2026, Molbio Diagnostics has a trailing 12-month revenue of $151M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,593,178 | |||
| Revenue | 151,250 | 160,129 | 117,965 | 99,018 |
| EBITDA | 34,494 | 36,169 | 29,771 | 22,088 |
| Net Income | 16,650 | 18,853 | 17,160 | 12,315 |
| Total Assets | 242,442 | 227,702 | 170,864 | 146,421 |
| Total Debt | 40,584 | 47,701 | 17,177 | 22,019 |
Molbio Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Molbio Diagnostics Comparisons
Industry
Financing
Details
Molbio Diagnostics Competitors (15)
One of Molbio Diagnostics’s 15 competitors is Trivitron Healthcare, a Formerly PE-Backed company based in Chennai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Trivitron Healthcare | Formerly PE-Backed | Chennai, India | ||||
| Shanghai Kehua Biological Engineering | Corporation | Shanghai, China | ||||
| Neovasc | Corporate Backed or Acquired | Richmond, Canada | ||||
| Sensa Core | Private Equity-Backed | Hyderabad, India | ||||
| Abbott | Corporation | Abbot Park, IL |
Molbio Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Molbio Diagnostics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Molbio Diagnostics Investments (3)
Molbio Diagnostics’s most recent deal was a Later Stage VC with OptraScan for . The deal was made on 06-Nov-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| OptraScan | 06-Nov-2024 | Later Stage VC | Diagnostic Equipment | ||
| Chayagraphics Healthcare | 20-Feb-2023 | Buyout/LBO | Distributors (Healthcare) | ||
| Prognosys Medical Systems | 20-Feb-2023 | Buyout/LBO | Diagnostic Equipment |
Molbio Diagnostics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Prognosys Medical Systems | Bangalore, India | 2004 |
Molbio Diagnostics FAQs
-
When was Molbio Diagnostics founded?
Molbio Diagnostics was founded in 2000.
-
Where is Molbio Diagnostics headquartered?
Molbio Diagnostics is headquartered in Verna, India.
-
What is the size of Molbio Diagnostics?
Molbio Diagnostics has 1,225 total employees.
-
What industry is Molbio Diagnostics in?
Molbio Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Molbio Diagnostics a private or public company?
Molbio Diagnostics is a Public company.
-
What is Molbio Diagnostics’s stock symbol?
The ticker symbol for Molbio Diagnostics is MOLBIO.
-
What is the current stock price of Molbio Diagnostics?
As of 13-Nov-2026 the stock price of Molbio Diagnostics is $15.88.
-
What is the current market cap of Molbio Diagnostics?
The current market capitalization of Molbio Diagnostics is $1.83B.
-
What is Molbio Diagnostics’s current revenue?
The trailing twelve month revenue for Molbio Diagnostics is $151M.
-
Who are Molbio Diagnostics’s competitors?
Trivitron Healthcare, Shanghai Kehua Biological Engineering, Neovasc, Sensa Core, and Abbott are some of the 15 competitors of Molbio Diagnostics.
-
What is Molbio Diagnostics’s annual earnings per share (EPS)?
Molbio Diagnostics’s EPS for 12 months was $0.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
